Abera Bioscience AB Sustainability Reports
Abera Bioscience AB is a biotechnology company focused on developing novel mucosal vaccines based on its proprietary vaccine platform technologies. The company designs vaccines for oral and nasal administration targeting seasonal, bacterial, and emerging pandemic pathogens.
Sector: Professional & technical services
Country: Sweden
Exchange: Nordic Growth Market
LEI: 549300IO3Q8IE2FDUS29
FIGI: BBG00YYC16B4
1 reports from 2024 to 2024
